Detalhe da pesquisa
1.
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO GUIDELINE (2017; Amended 2020, 2024).
J Urol
; : 101097JU0000000000003981, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38661067
2.
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment.
J Urol
; 211(4): 533-538, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38265030
3.
Prophylactic Use of Biologic Mesh in Ileal Conduit (PUBMIC): A Randomized Clinical Trial.
J Urol
; 211(6): 743-753, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38620056
4.
Efficacy of Intravesical Nadofaragene Firadenovec for Patients with BCG-Unresponsive Non-muscle Invasive Bladder Cancer: 5 Year Follow-Up from a Phase 3 Trial.
J Urol
; : 101097JU0000000000004020, 2024 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704840
5.
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
Lancet Oncol
; 24(6): 669-681, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37187202
6.
Perioperative mortality for radical cystectomy in the modern Era: experience from a tertiary referral center.
Int Braz J Urol
; 49(3): 351-358, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37115179
7.
Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 Cases.
J Urol
; 207(2): 302-313, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34994657
8.
Long-term renal function in patients with chronic kidney disease following radical cystectomy and orthotopic neobladder.
BJU Int
; 130(2): 200-207, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35044045
9.
Risk factors and natural history of parastomal hernia after radical cystectomy and ileal conduit.
BJU Int
; 130(3): 381-388, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34837315
10.
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Lancet Oncol
; 22(1): 107-117, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33253641
11.
Predictors of need for catheterisation and urinary retention after radical cystectomy and orthotopic neobladder in male patients.
BJU Int
; 128(3): 304-310, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33348465
12.
Stoma complications and quality of life in patients with Indiana pouch versus appendico/neo-appendico-umbilicostomy urinary diversions.
World J Urol
; 39(5): 1521-1529, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32651651
13.
Internal audit of an enhanced recovery after surgery protocol for radical cystectomy.
World J Urol
; 38(12): 3131-3137, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32112242
14.
An evaluation of the real world use and clinical utility of the Cxbladder Monitor assay in the follow-up of patients previously treated for bladder cancer.
BMC Urol
; 20(1): 12, 2020 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32046687
16.
Factors influencing intraoperative conversion from planned orthotopic to non-orthotopic urinary diversion during radical cystectomy.
World J Urol
; 37(9): 1851-1855, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30519743
17.
Extended hospital stay after radical cystectomy with enhanced recovery protocol.
Can J Urol
; 26(1): 9654-9659, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30797248
18.
The association between intraoperative fluid intake and postoperative complications in patients undergoing radical cystectomy with an enhanced recovery protocol.
World J Urol
; 36(3): 401-407, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29299662
20.
90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study.
World J Urol
; 35(6): 907-911, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27734131